🇺🇸 FDA
Patent

US 11472884

Humanized BCMA antibody and BCMA-CAR-T cells

granted A61KA61K2035/124A61K2039/505

Quick answer

US patent 11472884 (Humanized BCMA antibody and BCMA-CAR-T cells) held by Caribou Biosciences, Inc. expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Caribou Biosciences, Inc.
Grant date
Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2035/124, A61K2039/505, A61K2039/54, A61K2039/804